These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 22783929)

  • 1. Comparison of the oestrogen and progesterone receptor status in primary breast carcinomas as evaluated by immunohistochemistry and immunocytochemistry: a consecutive series of 267 patients.
    Domanski AM; Monsef N; Domanski HA; Grabau D; Fernö M
    Cytopathology; 2013 Feb; 24(1):21-5. PubMed ID: 22783929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fine needle aspirate cell blocks are reliable for detection of hormone receptors and HER-2 by immunohistochemistry in breast carcinoma.
    Bueno Angela SP; Viero RM; Soares CT
    Cytopathology; 2013 Feb; 24(1):26-32. PubMed ID: 22220518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multinational study of oestrogen and progesterone receptor immunocytochemistry on breast carcinoma fine needle aspirates.
    Marinšek ZP; Nolde N; Kardum-Skelin I; Nizzoli R; Onal B; Rezanko T; Tani E; Ostović KT; Vielh P; Schmitt F; Kocjan G
    Cytopathology; 2013 Feb; 24(1):7-20. PubMed ID: 23082931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunochemistry for oestrogen receptor, progesterone receptor and HER2 on cell blocks in primary breast carcinoma.
    Kumar SK; Gupta N; Rajwanshi A; Joshi K; Singh G
    Cytopathology; 2012 Jun; 23(3):181-6. PubMed ID: 21375607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial.
    Pentheroudakis G; Kalogeras KT; Wirtz RM; Grimani I; Zografos G; Gogas H; Stropp U; Pectasides D; Skarlos D; Hennig G; Samantas E; Bafaloukos D; Papakostas P; Kalofonos HP; Pavlidis N; Fountzilas G
    Breast Cancer Res Treat; 2009 Jul; 116(1):131-43. PubMed ID: 18668363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Re-evaluating adjuvant breast cancer trials: assessing hormone receptor status by immunohistochemical versus extraction assays.
    Regan MM; Viale G; Mastropasqua MG; Maiorano E; Golouh R; Carbone A; Brown B; Suurküla M; Langman G; Mazzucchelli L; Braye S; Grigolato P; Gelber RD; Castiglione-Gertsch M; Price KN; Coates AS; Goldhirsch A; Gusterson B;
    J Natl Cancer Inst; 2006 Nov; 98(21):1571-81. PubMed ID: 17077359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ER, PR, and Her2 immunocytochemistry on cell-transferred cytologic smears of primary and metastatic breast carcinomas: a comparison study with formalin-fixed cell blocks and surgical biopsies.
    Ferguson J; Chamberlain P; Cramer HM; Wu HH
    Diagn Cytopathol; 2013 Jul; 41(7):575-81. PubMed ID: 22807465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunohistochemical determination of hormonal receptors on cell-blocks from fine-needle cytopunctures of breast carcinoma].
    Briffod M; Le Doussal V; Spyratos F
    Bull Cancer; 2001 Oct; 88(10):1028-35. PubMed ID: 11713039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytological evaluation of biological prognostic markers from primary breast carcinomas.
    Makris A; Allred DC; Powles TJ; Dowsett M; Fernando IN; Trott PA; Ashley SE; Ormerod MG; Titley JC; Osborne CK
    Breast Cancer Res Treat; 1997 May; 44(1):65-74. PubMed ID: 9164679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunocytochemical evaluation of estrogen receptor on archival Papanicolaou-stained fine-needle aspirate smears.
    Krishnamurthy S; Dimashkieh H; Patel S; Sneige N
    Diagn Cytopathol; 2003 Dec; 29(6):309-14. PubMed ID: 14648786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunocytochemical assay of estrogen and progesterone receptors in fine needle aspirates from breast cancer patients.
    Nizzoli R; Bozzetti C; Savoldi L; Manotti L; Naldi N; Camisa R; Soresi AP; Guazzi A; Cocconi G
    Acta Cytol; 1994; 38(6):933-8. PubMed ID: 7992582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the results of immunocytochemical assays for biologic variables on preoperative fine-needle aspirates and on surgical specimens of primary breast carcinomas.
    Nizzoli R; Bozzetti C; Naldi N; Guazzi A; Gabrielli M; Michiara M; Camisa R; Barilli A; Cocconi G
    Cancer; 2000 Feb; 90(1):61-6. PubMed ID: 10692218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemistry on cell blocks from fine-needle cytopunctures of primary breast carcinomas and lymph node metastases.
    Briffod M; Hacène K; Le Doussal V
    Mod Pathol; 2000 Aug; 13(8):841-50. PubMed ID: 10955449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of estrogen and progesterone receptors measured by enzyme immunoassays in human breast tumor cytosols.
    Foekens JA; Portengen H; van Putten WL; Peters HA; Krijnen HL; Alexieva-Figusch J; Klijn JG
    Cancer Res; 1989 Nov; 49(21):5823-8. PubMed ID: 2676151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical correlation of steroid receptors and disease-free interval in 206 consecutive cases of breast cancer: validation of telequantification based on global scene segmentation.
    Ferrer Roca OF; Ramos A; Diaz Cardama A
    Anal Cell Pathol; 1995 Sep; 9(2):151-63. PubMed ID: 7492518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative assessment of proliferative activity and hormonal receptor status in carcinoma of the breast: a comparison of needle aspiration and needle-core biopsies to the surgical specimen.
    Railo M; Nordling S; Krogerus L; Sioris T; von Smitten K
    Diagn Cytopathol; 1996 Sep; 15(3):205-10. PubMed ID: 8955602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimation of hormone receptor status in fine-needle aspirates and paraffin-embedded sections from breast cancer using the novel rabbit monoclonal antibodies SP1 and SP2.
    Cano G; Milanezi F; Leitão D; Ricardo S; Brito MJ; Schmitt FC
    Diagn Cytopathol; 2003 Oct; 29(4):207-11. PubMed ID: 14506673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interobserver reproducibility of immunocytochemical estrogen- and progesterone receptor status assessment in breast cancer.
    Biesterfeld S; Veuskens U; Schmitz FJ; Amo-Takyi B; Böcking A
    Anticancer Res; 1996; 16(5A):2497-500. PubMed ID: 8917341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgical specimen can be replaced by core samples in assessment of ER, PR and HER-2 for invasive breast cancer.
    Sutela A; Vanninen R; Sudah M; Berg M; Kiviniemi V; Rummukainen J; Kataja V; Kärjä V
    Acta Oncol; 2008; 47(1):38-46. PubMed ID: 17851859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discordance in early breast cancer for tumour grade, estrogen receptor, progesteron receptors and human epidermal receptor-2 status between core needle biopsy and surgical excisional primary tumour.
    Lorgis V; Algros MP; Villanueva C; Chaigneau L; Thierry-Vuillemin A; Nguyen T; Demarchi M; Bazan F; Sautiere JL; Maisonnette-Lescot Y; Ringenbach F; Bontemps P; Pivot X
    Breast; 2011 Jun; 20(3):284-7. PubMed ID: 21288720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.